secwatch.observer — SEC 8-K summary
======================================

Issuer:     INOVIO PHARMACEUTICALS, INC. (INO)
CIK:        0001055726
Form:       8-K
Filed at:   2022-05-17T23:59:59+00:00
Accession:  0001193125-22-153110
Event type: other
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02, 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Inovio appoints CEO Shea to board; shareholders approve auditor and exec compensation vote
--------------------------------------------------------------------------------

- CEO Jacqueline Shea appointed to board following May 16, 2022 annual meeting; term until 2023 annual meeting.
- All seven director nominees elected; highest votes for David Weiner (53.2M), lowest for Lota Zoth (48.1M for).
- Ratification of Ernst & Young as auditor passed with 109.6M for, 6.7M against, 1.4M abstain.
- Advisory 'say-on-pay' vote passed with 40.8M for, 16.9M against, 0.7M abstain; broker non-votes 59.2M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1055726/000119312522153110/0001193125-22-153110-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1055726/000119312522153110/d338053d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-153110

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer